文献速递流行病学与生物统计医学人工智能与信息学

无症状与症状前SARS-CoV-2感染的发生及传播潜力:活系统综述与荟萃分析

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
PubMed 文献 · PLoS Med · 2020-09-22

该活系统综述纳入94项研究,估算SARS-CoV-2感染者全程无症状比例为20%(95%CI 17-25),在7项定义人群筛查随访研究中为31%(95%CI 26-37%)。症状前比例因异质性无法汇总;无症状感染者接触者的续发率相对风险为0.35(95%CI 0.10-1.27)。结论提示多数感染者不会全程无症状,需继续采取综合防控措施。

要点

  • 感染者全程无症状比例约20%,定义人群筛查随访研究中约31%。
  • 无症状感染者接触者的续发率低于有症状感染者,相对风险0.35(95%CI 0.10-1.27)。
  • 症状前与无症状传播均有贡献,需维持手卫生、口罩、检测追踪、隔离和社交距离等综合措施。

核心结论

  • 多数SARS-CoV-2感染者不会在感染全程保持无症状。
  • 症状前与无症状感染者对总体传播有贡献,支持继续采用综合预防措施。

研究设计与样本

  • 活系统综述与荟萃分析,检索PubMed、Embase、bioRxiv和medRxiv,最后一次检索为2020年6月10日。
  • 纳入经RT-PCR确诊、记录随访前后症状状态的研究或建模研究,共94项。
  • 一名评价者提取数据、第二名核实,分歧通过讨论或第三名评价者解决。

主要发现

  • 79项研究中,感染者全程无症状的总体估计为20%(95%CI 17-25),预测区间3%-67%。
  • 7项定义人群筛查后随访研究中,31%(95CI 26%-37%,预测区间24%-38%)保持无症状。
  • 症状前比例因异质性无法汇总。
  • 无症状感染接触者的续发率低于有症状感染接触者,相对风险0.35(95%CI 0.10-1.27)。
  • 建模研究提示,由症状前个体传播导致的感染比例高于无症状个体。

临床怎么用

  • 应继续实施加强手卫生、戴口罩、检测、追踪、隔离和社交距离等综合预防措施。
  • 对无症状感染者的接触者仍需开展追踪与防控,不能因续发率较低而放松。

局限性

  • 多数纳入研究并非为估计无症状感染比例而设计,存在选择偏倚风险。
  • 未考虑RT-PCR假阴性结果的可能影响,可能低估无症状感染比例。
  • 所用数据库未涵盖所有来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is disagreement about the level of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a living systematic review and meta-analysis to address three questions: (1) Amongst people who become infected with SARS-CoV-2, what proportion does not experience symptoms at all during their infection? (2) Amongst people with SARS-CoV-2 infection who are asymptomatic when diagnosed, what proportion will develop symptoms later? (3) What proportion of SARS-CoV-2 transmission is accounted for by people who are either asymptomatic throughout infection or presymptomatic? METHODS AND FINDINGS: We searched PubMed, Embase, bioRxiv, and medRxiv using a database of SARS-CoV-2 literature that is updated daily, on 25 March 2020, 20 April 2020, and 10 June 2020. Studies of people with SARS-CoV-2 diagnosed by reverse transcriptase PCR (RT-PCR) that documented follow-up and symptom status at the beginning and end of follow-up or modelling studies were included. One reviewer extracted data and a second verified the extraction, with disagreement resolved by discussion or a third reviewer. Risk of bias in empirical studies was assessed with an adapted checklist for case series, and the relevance and credibility of modelling studies were assessed using a published checklist. We included a total of 94 studies. The overall estimate of the proportion of people who become infected with SARS-CoV-2 and remain asymptomatic throughout infection was 20% (95% confidence interval [CI] 17-25) with a prediction interval of 3%-67% in 79 studies that addressed this review question. There was some evidence that biases in the selection of participants influence the estimate. In seven studies of defined populations screened for SARS-CoV-2 and then followed, 31% (95% CI 26%-37%, prediction interval 24%-38%) remained asymptomatic. The proportion of people that is presymptomatic could not be summarised, owing to heterogeneity. The secondary attack rate was lower in contacts of people with asymptomatic infection than those with symptomatic infection (relative risk 0.35, 95% CI 0.10-1.27). Modelling studies fit to data found a higher proportion of all SARS-CoV-2 infections resulting from transmission from presymptomatic individuals than from asymptomatic individuals. Limitations of the review include that most included studies were not designed to estimate the proportion of asymptomatic SARS-CoV-2 infections and were at risk of selection biases; we did not consider the possible impact of false negative RT-PCR results, which would underestimate the proportion of asymptomatic infections; and the database does not include all sources. CONCLUSIONS: The findings of this living systematic review suggest that most people who become infected with SARS-CoV-2 will not remain asymptomatic throughout the course of the infection. The contribution of presymptomatic and asymptomatic infections to overall SARS-CoV-2 transmission means that combination prevention measures, with enhanced hand hygiene, masks, testing tracing, and isolation strategies and social distancing, will continue to be needed.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020. PMID: 32960881. doi:10.1371/journal.pmed.1003346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。